(Q29619344)
Statements
Erlotinib plus gemcitabine compared with gemcitabine alone in patients with advanced pancreatic cancer: a phase III trial of the National Cancer Institute of Canada Clinical Trials Group (English)
Moore MJ
Goldstein D
Hamm J
Figer A
Hecht JR
Gallinger S
Au HJ
Murawa P
Walde D
Wolff RA
Campos D
Lim R
Ding K
Clark G
Voskoglou-Nomikos T
Ptasynski M
Parulekar W
20 May 2007
25
15
1960-6